Don't miss our holiday offer - up to 50% OFF!
Cerebrolysin – 60mg (10 vials)
$83.00
Cerebrolysin – 60mg – 10 Vials
Cerebrolysin is a porcine brain-derived peptide preparation investigated and used in certain countries in clinical settings for neurological conditions. Its composition and regulatory status vary by product and jurisdiction. This listing describes a 60mg, 10-vial presentation. Confirm the exact formulation, strength per vial, manufacturer, and authorization before publication or distribution.
Cerebrolysin – 60mg – 10 Vials
Product Overview
Cerebrolysin is a preparation derived from porcine brain proteins and peptides. It has been studied in neurological research, including investigations involving neuronal function and recovery following neurological injury.
This listing describes a product labeled 60mg and supplied in a pack of 10 vials. The exact composition, concentration, and presentation must be confirmed using the manufacturer’s official documentation. Do not assume that this listing is equivalent to a particular approved commercial formulation.
Product Details
- Product Name: Cerebrolysin
- Listed Strength: 60mg
- Package Quantity: 10 vials
- Product Category: Peptide Preparation
- Source and Composition: Confirm with manufacturer
- Formulation: Confirm with supplier
- Manufacturer: Confirm with supplier
- Storage Requirements: Follow verified manufacturer documentation
Scientific Background
Cerebrolysin preparations contain a mixture of low-molecular-weight peptides and amino acids derived from porcine brain proteins. They have been investigated for possible effects on neuronal processes in laboratory and clinical research.
Research findings and clinical recommendations vary. Evidence should not be interpreted as proof that every Cerebrolysin-labeled product is effective or appropriate for a particular neurological condition.
Supplier Verification
Before publishing or distributing this product, confirm:
- Whether 60mg refers to each vial or the entire package
- The exact composition and concentration
- The source material and manufacturing process
- Manufacturer identity and batch information
- Available quality and product documentation
- Storage and handling requirements
- Applicable regulatory authorization in the intended market
Important Safety and Regulatory Information
Cerebrolysin is not interchangeable with other peptide products or neurological medicines. Its safety, suitability, and approved uses depend on the exact formulation and local regulatory authorization. Potential adverse effects and contraindications should be assessed by a qualified healthcare professional.
This description is informational only and is not medical advice, a dosing guide, or a recommendation for self-administration. Do not make unsupported claims about neurological benefits, treatment outcomes, purity, or regulatory approval. Verify the product’s identity and documentation before making further claims.





Reviews
There are no reviews yet.